These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 16497801

  • 1. Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity.
    Attardi BJ, Hild SA, Reel JR.
    Endocrinology; 2006 Jun; 147(6):3016-26. PubMed ID: 16497801
    [Abstract] [Full Text] [Related]

  • 2. Dimethandrolone (7alpha,11beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase.
    Attardi BJ, Pham TC, Radler LC, Burgenson J, Hild SA, Reel JR.
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):214-22. PubMed ID: 18555683
    [Abstract] [Full Text] [Related]

  • 3. Development of dimethandrolone 17beta-undecanoate (DMAU) as an oral male hormonal contraceptive: induction of infertility and recovery of fertility in adult male rabbits.
    Attardi BJ, Engbring JA, Gropp D, Hild SA.
    J Androl; 2011 Jun; 32(5):530-40. PubMed ID: 21164142
    [Abstract] [Full Text] [Related]

  • 4. In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone.
    Attardi BJ, Burgenson J, Hild SA, Reel JR.
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):277-88. PubMed ID: 15120421
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive.
    Ayoub R, Page ST, Swerdloff RS, Liu PY, Amory JK, Leung A, Hull L, Blithe D, Christy A, Chao JH, Bremner WJ, Wang C.
    Andrology; 2017 Mar; 5(2):278-285. PubMed ID: 27907978
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities.
    Attardi BJ, Page ST, Hild SA, Coss CC, Matsumoto AM.
    J Steroid Biochem Mol Biol; 2010 Feb 15; 118(3):151-61. PubMed ID: 19941958
    [Abstract] [Full Text] [Related]

  • 7. The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects.
    Attardi BJ, Hild SA, Koduri S, Pham T, Pessaint L, Engbring J, Till B, Gropp D, Semon A, Reel JR.
    J Steroid Biochem Mol Biol; 2010 Oct 15; 122(4):212-8. PubMed ID: 20599615
    [Abstract] [Full Text] [Related]

  • 8. In vitro characterization of trimegestone: a new potent and selective progestin.
    Zhang Z, Lundeen SG, Zhu Y, Carver JM, Winneker RC.
    Steroids; 2000 Oct 15; 65(10-11):637-43. PubMed ID: 11108870
    [Abstract] [Full Text] [Related]

  • 9. Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
    Pasapera AM, Gutiérrez-Sagal R, García-Becerra R, Ulloa-Aguirre A, Savouret JF.
    Endocrine; 2001 Dec 15; 16(3):217-25. PubMed ID: 11954666
    [Abstract] [Full Text] [Related]

  • 10. CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.
    Attardi BJ, Burgenson J, Hild SA, Reel JR, Blye RP.
    Mol Cell Endocrinol; 2002 Feb 25; 188(1-2):111-23. PubMed ID: 11911951
    [Abstract] [Full Text] [Related]

  • 11. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
    Horwitz KB.
    Endocrinology; 1985 Jun 25; 116(6):2236-45. PubMed ID: 4039656
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.
    Attardi BJ, Marck BT, Matsumoto AM, Koduri S, Hild SA.
    J Androl; 2011 Jun 25; 32(2):183-92. PubMed ID: 20798389
    [Abstract] [Full Text] [Related]

  • 13. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A, Hahn DW, McGuire JL.
    Am J Obstet Gynecol; 1992 Oct 25; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [Abstract] [Full Text] [Related]

  • 14. Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive.
    Surampudi P, Page ST, Swerdloff RS, Nya-Ngatchou JJ, Liu PY, Amory JK, Leung A, Hull L, Blithe DL, Woo J, Bremner WJ, Wang C.
    Andrology; 2014 Jul 25; 2(4):579-587. PubMed ID: 24789057
    [Abstract] [Full Text] [Related]

  • 15. Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β-MNTDC in healthy men.
    Yuen F, Thirumalai A, Fernando FA, Swerdloff RS, Liu PY, Pak Y, Hull L, Bross R, Blithe DL, Long JE, Page ST, Wang C.
    Andrology; 2021 Sep 25; 9(5):1526-1539. PubMed ID: 33908182
    [Abstract] [Full Text] [Related]

  • 16. Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones.
    Schoonen WG, Deckers G, de Gooijer ME, de Ries R, Mathijssen-Mommers G, Hamersma H, Kloosterboer HJ.
    J Steroid Biochem Mol Biol; 2000 Oct 25; 74(3):109-23. PubMed ID: 11086230
    [Abstract] [Full Text] [Related]

  • 17. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH.
    Contraception; 1996 Oct 25; 54(4):243-51. PubMed ID: 8922878
    [Abstract] [Full Text] [Related]

  • 18. Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
    Markiewicz L, Gurpide E.
    Methods Find Exp Clin Pharmacol; 1997 May 25; 19(4):215-22. PubMed ID: 9228646
    [Abstract] [Full Text] [Related]

  • 19. Comparison of 7α-methyl-19-nortestosterone effectiveness alone or combined with progestins on androgen receptor mediated-transactivation.
    García-Becerra R, Ordaz-Rosado D, Noé G, Chávez B, Cooney AJ, Larrea F.
    Reproduction; 2012 Feb 25; 143(2):211-9. PubMed ID: 22065861
    [Abstract] [Full Text] [Related]

  • 20. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E, Jansen HJ, Riteco JA, Brouwer A, van der Burg B.
    Toxicol Sci; 2005 Jan 25; 83(1):136-48. PubMed ID: 15483189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.